RESUMO
The use of energy-based devices to treat genitourinary syndrome of menopause, termed vaginal thermotherapy (VTT), has gained significant interest in recent years. Among the primary safety concerns of this relatively new procedure is the possibility of unintentionally heating tissues adjacent to the vaginal wall, i.e., heating too deeply. Herein we use numerical simulations to evaluate monopolar radiofrequency-based (RF) VTT specifically focusing on the resultant depth of heating through a range of input parameters. Varying RF power, exposure time, and the simulated rate of blood perfusion, we map the parameter space identifying which combinations of input parameters are likely to heat past the depth of the vaginal wall and affect adjacent tissue. We found that the device parameters commonly used in the literature are likely to heat past the vaginal wall and merit further investigation. In addition, we found that the parameter typically used to describe VTT devices, total energy delivered, does not reliably indicate the resultant depth of heat dispersion.
Assuntos
Calefação , Hipertermia Induzida , Vagina , Feminino , Temperatura Alta , Humanos , Hipertermia Induzida/efeitos adversos , Ondas de Rádio/efeitos adversosRESUMO
The recent increase in US Food and Drug Administration-approved weight-loss devices has diversified obesity treatment options. The regulatory pathways for endoscopically placed weight-loss devices and considerations for clinical trials are discussed, including the benefit-risk paradigm intended to aid in weight-loss-device trial development. Also discussed is the benefit-risk analysis of recently approved endoscopic devices. A strategic priority of the FDA Center for Devices and Radiological Health is to increase the use of patient input in decision making. Thus, we consider how endoscopic weight-loss devices with profiles similar to those that have been approved may be viewed in a patient preference study.